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Abstract
Purpose. To illustrate the propensity of meningeal hemangiopericytoma to spread extraneurally, as a distinction to the
ordinary meningioma.
Patients or subjects. A patient with long history of meningeal hemangiopericytoma was reported.
Methods. A case report on meningeal hemangiopericytoma with a literature review was presented.
Results. The patient has multiple local recurrence as well as distant metastases.This is the ® rst case report of metastatic
meningeal hemangiopericytoma causing compression of the pancreatic head.The patient also has biopsy-proven pulmonary
metastases.The patient received both local and systemic therapy.
Discussion. It is important to recognize the distinctive features differentiating meningeal hemangiopericytoma from menin-
gioma.The positive impact of clinico-pathological correlation on patient management is emphasized.
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Introduction
Meningeal hemangiopericytoma (MH) is a rare
tumor. The incidence of this malignant neoplasm
ranges from 2 to 4% of that of meningiomas,
1,2 and
makes up only less than 1% of all central nervous
system (CNS) tumors.
2 It was postulated that MH
arises from meningealcapillary pericytes or precursor
cells with angioblastic tendencies.
3,4The difficulty in
recognizing MH as a separate entity from menin-
gioma may have contributed to its low incidence.It is
important to recognize this tumor because of its
propensity to spread extraneurally, as a clear distinc-
tion to the ordinarymeningioma,which has significant
impact on both management and prognosis. Herein,
we report a case of MH with multiple local recur-
rence as well as distant metastases.To our knowledge,
this is the ® rst report, in the English literature, of
metastatic MH presented as a mass compressing the
head of the pancreas.
Case report
A 48-year-old African± Americanman was referredto
the Department of Radiation Oncologyfor considera-
tion of palliative radiotherapy to his brain. The
consultation requestform stated `the patient has long
history of meningioma, status post local resection
times three. He also had pancreatic cancer with lung
metastases,status postWhipple procedure.Currently,
he has more headaches and imaging study showed a
mass’. The referral service was concerned that the
brain lesion might be from a pancreatic primary.
During the patient’s ® rst visit to the Department
of Radiation Oncology, he stated that there was
deterioration of his left-sided weakness and right-
sided vision in addition to the headache.These were
the same symptoms he initially presented7 years ago.
A head computed tomography (CT) scan was then
performed that showed a mass in the right occipito-
parietal area. The patient subsequently underwent
craniotomyand resection.Intraoperatively,the tumor
was noted to be veryvascular and invading the sagittal
sinus. Final pathology reported benign meningioma
of angioblastic type. The patient was told that the
tumor was benign. His symptoms improved post-
operatively and he did not receive any adjuvant treat-
ment such as radiotherapy. He remained symptom
free until 2 years ago, when he presented to another
hospital with headache. Neuro-imaging (both CT
and magnetic resonance imaging (MRI)) showed a
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DOI:10.1080/13577140020025887recurrent mass in the right occipito-parietal region
that enhanced well with gadolinium, and there were
multiple ¯ ow voids. An angiogram with vascular
embolization was performed pre-operatively in an
attempt to decreasevascularity.The patient underwent
a second craniotomy and resection of the mass. A
subgaleal drain was used because of the vascularity.
Pathology reported meningeal hemangiopericytoma
(Fig. 1). The postoperative course was complicated
by removal of the retained fragment of the subgaleal
drain, an emergent decompression of an intracer-
ebral hemorrhage in the right surgical bed, resection
of the residual tumor and repair of a subgaleal
cerebro-spinal ¯ uid leak. The patient recovered
eventually without any neurological sequelae. Again,
the patient did not receive any adjuvant treatment.
One year ago, the patient presented to the same
hospital with abdominal pain and jaundice. Physical
examination revealed an icteric conjunctiva and a
soft non-distended abdomen with some degree of
epigastric tenderness.There were no palpable masses,
organomegaly or lymphadenopathy. Chest X-ray was
normal. CT scan (Fig. 2) of the abdomen
demonstrated a 3 cm mass compressing the head of
the pancreas causing intra- and extra-hepatic biliary
tract dilatation, suggestive of carcinoma. No other
abnormality was noted.The patient then underwent
exploratory laparotomy and Whipple procedure.
Pathologyinitiallyreportedundifferentiatedmalignant
neoplasm. Further studies including immuno-
histochemistry in our hospital con® rmed that the
pancreatic head mass was indeed hemangiopericy-
toma.The mass was purely extra-pancreatic in origin
and the pancreatic tissue was normal (Fig. 3). The
patient again recoveredbut was then lost to follow-up.
The patient has now returned with a 2-month
history of intermittent headache, increasing left-
sided weakness and worsening of his right vision.
Physical examination revealed the patient was awake
and oriented with decreasedright visual acuity.Other
cranial nerves were otherwise normal. He had
unsteady gait with decreased power and sensation on
his left-sided extremities. Other examinations were
normal.Laboratory tests includingliver functionwere
within normallimits.MRIof the brain (Fig.4) showed
a large 5 3 6 3 5 cm
3 inhomogeneous mass in the
right occipito-parietal region. The mass was extra-
axial with a dural tail and contained a large cystic
component.It extended across the falx to the left and
also invaded the superior sagittal sinus. Chest X-ray
Fig. 1. Meningeal hemangiopericytoma shown on high-power
® eld.
Fig. 2. Computed tomography scan of the abdomen showing a
3 cm mass compressing the pancreatic head.
Fig. 3. Low-power ® eld shows meningeal hemangiopericytoma
(left) separated from the normal pancreatic tissue (right) by
connective tissues.
Fig. 4. Axial image of a magnetic resonance imaging scan
shows a large right occipito-parietal mass.
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the lung parenchyma including the left lingula, right
peri-hilarand rightlung base.Therewas no significant
lymphadenopathy. CT of the abdomen was normal
without any metastatic disease. There was no bony
metastasis on bone scan.
The patient was started on decadronwith improve-
ment of his symptoms. A CT-guided biopsy of the
lung nodules was performed.The pathology showed
metastatic hemangiopericytoma.The patient was to
undergo further resection of the intra-cranial recur-
rentmass followed by adjuvant radiotherapy.Systemic
chemotherapy comprising adriamycin and ifosfa-
mide was also planned in view of its sarcoma-like
behavior.
Discussion
It is very unusual for primary CNS tumors to spread
outside the craniospinal neural axis.
5 Extraneural
metastasis is, however, common in hemangiopericy-
toma.
2The other CNS tumor to metastasize in this
manneris medulloblastoma.
6The most commonsites
of metastases in descendingfrequency are bone,lung
and liver.
2,7,8To the best of our knowledge,this is the
® rst case, in the English literature, of metastatic
hemangiopericytomapresentedasa mass compressing
the head of the pancreas, mimicking carcinoma of
pancreas. The patient actually had obstructive
jaundice and underwent Whipple procedure.
However, there is still a small probability that this
intra-abdominal mass could be second primary
hemangiopericytoma arising from the pericapillary
cells in the local blood vessels rather than metastasis
from the distant meningealhemangiopericytoma.The
other case of metastatic MH reported by Guthrie et
al.
2 was in the retroperitoneum but no exact location
was speci® ed. It was even more interesting to note in
the surgical specimen that all pancreatic tissues were
normal and the intra-abdominal mass noted on the
CT and ultrasonography (US) was purely extra-
pancreatic in origin. The systemic dissemination of
primary CNS tumors via ventriculo-peritoneal (VP)
shunts,although uncommon,has been reported.
5,9,10
Other proposed mechanisms include neurosurgical
interventionresultingin permeationof neoplasticcells
to the vascular and lymphatic systems,
9 and
treatment-related immunosuppression.
6 In this case,
there was no placement of VP shunt and the patient
was not immunosuppressed.However, he underwent
four surgical interventions (for resection of recurrent
tumor,removalof retaineddrainfragment,decompres-
sion of intracranial hemorrhageand repair of subgaleal
cerebrospinal ¯ uid leak, respectively) at the time of
® rst local recurrence. This may have been the
mechanism by which the malignant cells gain access
into the lympho-vascular space to spread distantly.
This case further illustrates several distinctive
features differentiating MH from the meningioma.
MH is morecommonin males (55± 70%) ascompared
with meningioma (35%), with the average age at
diagnosis between 38 and 42 years.
1,2 The patient
was 41 years old when he was ® rst diagnosed. MH
has an aggressive behavior and tends to recur both
locally and distantly. The median recurrence-free
interval was between 40 and 50 months, with an
actuarial 5-, 10-, and 15-year recurrence rate of 65,
76 and 87%, respectively.
2,8 The ® rst local recur-
rence occurred approximately 50 months after initial
diagnosis in this patient. MH tends to re-recur at
shorter intervals thereafter, as evidenced in this case.
The patient recurredsystemically14 monthslater after
® rst local recurrence, and further local and distant
(lung) recurrencestook place in another 17 months.It
is important to know the natural history of MH and
long-termfollow-up is needed.Thepathologic features
of various specimens obtained at different times were
similar.This is in contrast to that of ordinary menin-
gioma, which usually shows malignant progression in
cytological features at recurrence.
There is still no consensus on the terminology and
histogenesis of MH. The nomenclature of angiob-
lastic meningioma(hemangiopericytictype) was used
in the ® rst pathologic diagnosis and MH was used in
the subsequent pathologic diagnoses.The malignant
cell arises from either peri-capillary cells or pericytes
of Zimmerman and can occur wherever capillaries
are present. In theWorld Health Organization’s clas-
si® cation of 1979, these tumors were included as a
subgroup of meningioma, but for some authors they
should not be classi® ed as meningiomas.In contrast
to the ordinarymeningioma,MH tends to recur both
locally and distantly.It was interestingto note that, in
this case, the pathologist at the outside hospital
reported the resected abdominal mass as undifferen-
tiated malignantneoplasm.Thepathologist mostlikely
has no knowledge of the patient’s previous history of
MH. However, after review of the pathologic
specimen here in our hospital, the diagnosis of MH
is made. This again stressed the importance of
clinico-pathological correlation that has direct
impact on patient management. More recently,
advances in cytogenetics
11 and immunohistochem-
istry
12have provided additional tools to differentiate
MH from the ordinary meningioma. Using cytoge-
netic studies, monosomy or partial deletion of
chromosome 22 was demonstrated in 66% of
ordinary meningioma but none in MH.The immu-
notyping studies of MH included positivity of
vimentin (85%), factor XIIIa (78%) in individual
scattered cells, Leu-7 (70%), and CD34 (33%) in a
weak, patchy pattern. The ordinary meningioma
characteristically expressed epithelial membrane
antibody (80%) and S-100 protein (80%); CD34
reactivity (60%) was patchy and weak. Signi® cant
reactivity for P53 protein was detected in 5% of
meningioma but in 52% of MH.
12
Surgeryis the gold standard for the initial manage-
ment of MH.
13 If MH is suspected, arteriography
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tion to reducethe risk of intra-operative hemorrhage.
A gross total resection should at least be attempted at
the time of initial surgery. Adjuvant radiotherapy is
strongly recommended if resection is incomplete. In
a recent Mayo Clinic series,surgery again was shown
to be important for the successful treatment of
patients with recurrent MH.
14This series also found
radiosurgeryplayed a role in the treatment of smaller
recurrent CNS lesions. Radiotherapy was helpful in
the management of unresectable tumors and
metastatic disease. Adriamycin-based chemotherapy
was administered in seven patients (21%) and there
was only one partial response that lasted 8 months.
In view of his age and reasonable performancestatus,
as well as long natural history of disease, the patient
in this case was recommended to undergo further
neurosurgical intervention, followed by radiotherapy
to maximize the local control. He would also receive
systemic chemotherapy comprising adriamycin and
ifosfamide, frequently used in treating soft tissue
sarcoma metastasizing to the lung.
Last butnotleast,this caseillustratesthe importance
of good historytaking and reviewingof all past medical
records including previous pathological slides. The
patient was referredto the radiotherapy department as
having a stable meningiomaand widespreadmetastatic
carcinomaof the pancreas.He was not offered surgical
intervention to the brain. However, after a thorough
history taking and review of medical records,
pathologicalslidesincludingthosefromanotherhospital
and additional immunohistochemistry studies, the
patient’s clinical picture became clear and he was
managed appropriately.
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